TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mabpharm Limited ( (HK:2181) ) has provided an announcement.
Mabpharm Limited has announced that its board of directors will convene on March 26, 2025, to review and approve the company’s annual financial results for the year ending December 31, 2024. This meeting is significant as it will address the company’s financial performance and any other business matters, potentially impacting its market positioning and stakeholder interests.
More about Mabpharm Limited
Mabpharm Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and commercialization of innovative drugs, primarily targeting the healthcare market.
YTD Price Performance: 96.43%
Average Trading Volume: 109,375
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.02B
For a thorough assessment of 2181 stock, go to TipRanks’ Stock Analysis page.